Global Speech Biomarkers Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends
Publisher : MRA | Format : PDF
Global Speech Biomarkers Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Speech biomarkers are techniques for identifying diseases by the rhythm, frequency, pitch, and breathing of human voices
Speech Biomarkers report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global Speech Biomarkers market is projected to reach US$ 1069.9 million in 2033, increasing from US$ 520 million in 2023, with the CAGR of 11.0% during the period of 2023 to 2033. Demand from Mental Disorder and Respiratory Failure are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Speech Biomarkers industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Speech Biomarkers key companies include Boston Technology Corp., Cogito Corp., IBM Corp., conversation HEALTH Group, Winterlight Labs Inc., Vocalis Health, Inc., Mayo Clinic Inc., Medical Information Technology, Inc. and Sonde Health, Inc., etc. Boston Technology Corp., Cogito Corp., IBM Corp. are top 3 players and held % share in total in 2023.
Speech Biomarkers can be divided into Frequency, Amplitude, Error Rate and Pronunciation Time, etc. Frequency is the mainstream product in the market, accounting for % share globally in 2023.
Speech Biomarkers is widely used in various fields, such as Mental Disorder, Respiratory Failure and Other,, etc. Mental Disorder provides greatest supports to the Speech Biomarkers industry development. In 2023, global % share of Speech Biomarkers went into Mental Disorder filed.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Speech Biomarkers market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Boston Technology Corp.
Cogito Corp.
IBM Corp.
conversation HEALTH Group
Winterlight Labs Inc.
Vocalis Health, Inc.
Mayo Clinic Inc.
Medical Information Technology, Inc.
Sonde Health, Inc.
PureTech Health Plc
Orbita Inc.
MediTECH Electronic GmbH
Kintsugi Mindful Wellness
Ellipsis Health
Winter Light Labs
Voice Health Tech
Segment by Type
Frequency
Amplitude
Error Rate
Pronunciation Time
Mental Disorder
Respiratory Failure
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Speech Biomarkers market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Speech Biomarkers introduction, etc. Speech Biomarkers Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRA Research’s Conclusions of Speech Biomarkers market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRA Research.
Speech Biomarkers report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global Speech Biomarkers market is projected to reach US$ 1069.9 million in 2033, increasing from US$ 520 million in 2023, with the CAGR of 11.0% during the period of 2023 to 2033. Demand from Mental Disorder and Respiratory Failure are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Speech Biomarkers industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Speech Biomarkers key companies include Boston Technology Corp., Cogito Corp., IBM Corp., conversation HEALTH Group, Winterlight Labs Inc., Vocalis Health, Inc., Mayo Clinic Inc., Medical Information Technology, Inc. and Sonde Health, Inc., etc. Boston Technology Corp., Cogito Corp., IBM Corp. are top 3 players and held % share in total in 2023.
Speech Biomarkers can be divided into Frequency, Amplitude, Error Rate and Pronunciation Time, etc. Frequency is the mainstream product in the market, accounting for % share globally in 2023.
Speech Biomarkers is widely used in various fields, such as Mental Disorder, Respiratory Failure and Other,, etc. Mental Disorder provides greatest supports to the Speech Biomarkers industry development. In 2023, global % share of Speech Biomarkers went into Mental Disorder filed.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Speech Biomarkers market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Boston Technology Corp.
Cogito Corp.
IBM Corp.
conversation HEALTH Group
Winterlight Labs Inc.
Vocalis Health, Inc.
Mayo Clinic Inc.
Medical Information Technology, Inc.
Sonde Health, Inc.
PureTech Health Plc
Orbita Inc.
MediTECH Electronic GmbH
Kintsugi Mindful Wellness
Ellipsis Health
Winter Light Labs
Voice Health Tech
Segment by Type
Frequency
Amplitude
Error Rate
Pronunciation Time
Segment by Application
Mental Disorder
Respiratory Failure
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Speech Biomarkers market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Speech Biomarkers introduction, etc. Speech Biomarkers Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRA Research’s Conclusions of Speech Biomarkers market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRA Research.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices